BioStem Technologies, Inc. (BSEM)
5.132
-0.07
(-1.31%)
USD |
OTCM |
Apr 10, 16:00
BioStem Technologies Total Liabilities (Quarterly) : 11.06M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 12.33M |
| Iovance Biotherapeutics, Inc. | 214.59M |
| Protokinetix, Inc. | 0.2272M |
| GB Sciences, Inc. | 5.974M |
| Travere Therapeutics, Inc. | 490.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 50.20M |
| Shareholders Equity (Quarterly) | 39.14M |
| Debt to Equity Ratio | 0.0851 |
| Current Ratio | 4.118 |
| Net Debt Paydown Yield | 0.36% |